Gennaro Pagano

PASADENA trial: prasinezumab in early Parkinson’s disease 1:24
PASADENA trial: prasinezumab in early Parkinson’s disease
Gennaro Pagano • 10 Mar 2021
Prasinezumab: an anti-alpha-synuclein antibody in Parkinson’s disease 1:29
Prasinezumab: an anti-alpha-synuclein antibody in Parkinson’s disease
Gennaro Pagano • 10 Mar 2021
Learnings from the PASADENA trial in Parkinson’s disease 1:49
Learnings from the PASADENA trial in Parkinson’s disease
Gennaro Pagano • 10 Mar 2021
Age at onset and Parkinson’s disease progression 1:10
Age at onset and Parkinson’s disease progression
Gennaro Pagano • 10 Mar 2021
The field of Parkinson’s disease research is expanding 1:24
The field of Parkinson’s disease research is expanding
Gennaro Pagano • 10 Mar 2021
The content of VJNeurology is intended for healthcare professionals